2016 Jul 01
What doctors know about how bad it is, and won’t say
Many terminal cancer patients don't realize they are dying, according to a study by Holly Prigerson, Ph.D. Read more
2016 Jul 01
Not just a shot in the dark
Researchers and clinicians gather to reflect on Cancer Moonshot mission Read more
2016 Jun 30
Weill Cornell joins national Oncology Care Model project
Weill Cornell Medicine, NewYork-Presbyterian and Columbia University Medical Center are among nearly 200 physician group practices and 17 health insurance companies participating in the Medicare arm of the Oncology Care Model, which includes more than 3,200 oncologists. Read more
2016 Jun 29
FDA grants Napabucasin orphan status for gastric cancer
The FDA has granted an orphan drug designation to the STAT3-targeted agent napabucasin as a treatment for patients with gastric or gastroesophageal junction cancer, based on early-phase research by Manish Shah, M.D. Read more
2016 Jun 28
Leonard named as 2016 Manhattan Light The Night Corporate Chair
The New York City Chapter of The Leukemia & Lymphoma Society (LLS) has announced John P. Leonard, M.D., as its 2016 Manhattan Light The Night® corporate chair. Read more
2016 Jun 28
Weill Cornell team publishes details of precision medicine knowledgebase of somatic tumor mutations
Olivier Elemento, Ph.D., and colleagues describe their data model that links variants to both tumor- and tissue-specific interpretations. Read more
2016 Jun 28
Device registry required to determine efficacy of newest prostate cancer treatment
Jim Hu, M.D., weighs in on new prostate cancer treatment, high-intensity focused ultrasound. Read more
2016 Jun 27
Mantle cell lymphoma treatment: plus ça change…
Peter Martin, M.D., comments on the results of a new immunochemotherapy regimen for the treatment of mantle cell lymphoma. Read more
2016 Jun 24
Ablation of small renal cancer associated with “significantly lower costs” than either partial or radical nephrectomy
For older patients with small (T1a) renal cancer, percutaneous ablation is associated with much lower costs than partial or radical nephrectomy, according to Adam D. Talenfeld, M.D. Read more
2016 Jun 22
How precision medicine will shift from research to clinical care
Marcin Imielinski, M.D., Ph.D., discusses the potential of precision medicine or cancer care. Read more
2016 Jun 21
Preventing hair loss from chemotherapy
It was a patient who inspired Tessa Cigler, M.D., to investigate the use of "cold caps" to prevent hair loss during chemotherapy. Read more
2016 Jun 20
Epigenome evolution may play key role in cancer progression
Certain types of cancer may be even more shifty and difficult to target than previously thought, due to continuous changes in cell programming. Read more
2016 Jun 16
Relaxation techniques ease patients' fear, anxiety about radiation treatments
A pilot project in radiation oncology has found that a relaxation wellness intervention can provide relief for anxious patients. Read more
2016 Jun 15
More evidence needed in using radiotherapy with immunotherapy
Despite very promising pre-clinical results and some clinical success, there is still much need to generate solid evidence demonstrating the efficacy of combining radiation with immunotherapy, according to Silvia Formenti, M.D., and Sandra Demaria, M.D. Read more
2016 Jun 12
Cancer drug prices higher in U.S., yet relatively affordable
David Nanus, M.D., discusses a study that examined the relative cost of cancer drugs. Read more
2016 Jun 09
The Pediatric Oncologist Paying It Forward at the Mini 10K
Lisa Roth, M.D., on running a race on behalf of a patient and herself, as a lymphoma survivor. Read more
2016 Jun 07
Chimeric antigen receptor T cells exhibit efficacy in advanced lymphoma
John Leonard, M.D., comments on research into the use of engineered CAR-T cells in the treatment of aggressive lymphomas. Read more
2016 Jun 06
FDA approves drug combo for kidney cancer
Ana Molina, M.D., comments on a new treatment for kidney cancer. Read more
2016 Jun 06
Sharing our collective wisdom at ASCO16
A variety of Meyer Cancer Center research and clinical results were showcased at the ASCO Annual Meeting in Chicago Read more
2016 Jun 06
Innovative immunotherapy more effective in treating an aggressive lymphoma than chemotherapy
A drug that recruits immune cells to fight an aggressive form of lymphoma that disproportionately affects minorities in the United States appears to be more effective than chemotherapy, according to Adrienne Phillips, M.D. Read more
